debate: are novel targets such as her2 ready for prime time in colorectal cancer? - no
Published 7 years ago • 146 plays • Length 15:52Download video MP4
Download video MP3
Similar videos
-
22:10
novel agents and targets in colorectal cancer
-
8:59
debate: is observation without surgery reasonable for rectal cancers achieving a clinical cr? -no
-
23:09
colorectal cancer: updates on novel agents and targets
-
31:17
molecular testing and the role of her2 in managing advanced colorectal cancer
-
13:18
debate 1: first-line treatment of metastatic colorectal cancer - calgb 80405
-
15:00
controversy debate 4: treatment algorithms in metastatic crc - nccn guidelines
-
2:23
biomarker testing and targeted therapies in colorectal cancer
-
11:54
debate: targeted therapy for ras/braf wt left sided colon cancers - bevacizumab or egfr antibodies
-
7:37
debate: msi high colon cancer - upfront chemotherapy
-
11:00
updates on treatment algorithms in metastatic crc in 2017 - left vs. right colon cancer
-
8:44
debate: optimal salvage therapy for refractory colon cancer? - tas102 or regorafenib
-
27:23
key insights in colorectal cancer
-
1:01:21
lunch and learn: updates in colorectal cancer
-
9:12
debate: is there an optimal treatment for refractory colorectal cancer? - immunotherapy
-
25:06
colorectal cancer: sequencing and therapeutic approaches in first- and next-line treatment
-
1:00
how i found out i had colon cancer: i saw the mass during my colonoscopy!
-
36:12
her2-positive metastatic colorectal cancer: unraveling game-changing treatment approaches
-
16:38
the her-2 pathway in gi cancer